Nuzenio

Pharmalive

Pharmalive entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 18 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 13:10:50 GMTVistagen’s repeat-dose anxiety nasal spray can’t beat placebo in mid-stage study - PharmaLive
Fri, 07 Aug 2026 13:02:22 GMTFDA approves Replimmune’s immunotherapy for advanced melanoma - PharmaLive
Thu, 06 Aug 2026 12:30:21 GMTSanofi pauses mid-stage lung study amid new CEO’s ‘rigorous portfolio prioritization’ - PharmaLive
Wed, 05 Aug 2026 20:17:20 GMTTakeda wins FDA approval for first drug to treat full range of narcolepsy type 1 symptoms - PharmaLive
Wed, 05 Aug 2026 10:00:30 GMTInnovation times three - PharmaLive
Wed, 05 Aug 2026 09:46:56 GMTPurpose-building an AI offering for drug development - PharmaLive

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pharmalive.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.